Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Yes, the market is liking what RGBP has to say now and what is in development. Additionally, the Federal Reserve held even on interest rates again today which is good for the market in general. As we go forward the table is set here for pps appreciation.
$RGBP bullish move with today's presentation!
RGBP has a strong developing story in the emerging fields of advanced cancer treatments and for other important diseases.
Regen BioPharma, Inc. is a publicly traded biotechnology company (PINK: RGBP) and (PINK: RGBPP). The Company is focused on the immunology and immunotherapy space. The Company is focused on rapidly advancing novel technologies through pre-clinical and Phase I/ II clinical trials. Currently, the Company is focused on mRNA and small molecule therapies for treating cancer and autoimmune disorders. Additional information on Regen BioPharma is available athttp://www.regenbiopharmainc.com.
Very good to see RGBP management directly presenting at the important investor conference today. This is the best way to get a company's progress into the spotlight for everyone to review.
Regena BioPharma, Inc. to Discuss Confirmation Study Results on Its DuraCar Program at the Emerging Growth Conference on November 1, 2023 https://finance.yahoo.com/news/regen-biopharma-inc-discuss-confirmation-133000016.html?soc_src=social-sh&soc_trk=tw&tsrc=twtr
$RGBP Presenting on the Emerging Growth Conference 64 Day 1 on November 1 Register Now
https://goto.webcasts.com/starthere.jsp?ei=1603286&tp_key=f701725cb0&sti=globe
Have not been here for a long time.. Wow ,what a disaster after the reverse split... Most happy I sold my shares prior.
rgbp--->crust-face_koosimodo_gonga_save_du_world("du"_for_dumpster)
Hey, Fatman and Robbing will again present at that bogus Emerging Conmen conference on the 1st. It is always a blast to hear Dumbass Dave sputter and tell us nothing and to watch Harry Flander nod off on screen.
OMG! THIS IS HUGE! THE KONMAN KOOS IS GOING TO..WAIT FOR IT...WAIT FOR IT....TALK ABOUT WHAT WAS SAID IN THE PR ABOUT CONFIRMATORY ROUTINE LAB RESULTS THAT PROVE NOTHING OTHER THAN IT THEY WERE ABLE TO DUPLICATE A SIMPLE IN VITRO LAB RESULT! THIS SHOULD SURELY MAKE THE STOCK POP TO AT LEAST $5!
BTW, DID YOU SEE THE NEWS ON REGEN'S "BIG PHARMA" PARTNER ONCOLOGY PHARMA?
$RGBP NEWS! @TheRegenBio Regena BioPharma, Inc. to Discuss Confirmation Study Results on Its DuraCar Program at the Emerging Growth Conference on November 1, 2023 https://finance.yahoo.com/news/regen-biopharma-inc-discuss-confirmation-133000016.html?soc_src=social-sh&soc_trk=tw&tsrc=twtr via @YahooFinance @frontpagestocks
Taking about "right decisions," how did the right decisions about the reverse split work out for the pathetic lying piece of crap CEO?
Also remember that the scumbag CEO who lies through his veneers that hide his rotten teeth and paid his brother $319K to do absolutely nothing was supposed to focus on DouchbagCellVax. These typical preclinical lab tests prove absolutely nothing about Nerf. And what is the pIt willan now for nerf? No one is going to give the fat bastard money. NERF will die on the vine just line HemaX and DcellVax.
What's funny is how old is NR2F6 , and in the article there using "unexpected and potentially extremely useful findings" , oh OK .
Second Confirmatory - I'm crying laughing
"Having a second confirmatory study gives us confidence we are making the right decision to pursue these novel cell therapies focused on autoimmunity," says Dr. David Koos, Chairman and CEO of the company. "I expect that after consulting with our Board of Advisors and internally, the Company will soon have a clear picture of the specific indications and approaches it will pursue."
$RGBP
New posters yet with the same pump. Some things never change on this clown show website
But the Koos klown posse are telling us this is the real deal for the millionth time in over a decade? Are you sure it isn’t for realsie THIS time around?
Hilarious , "Confirmatory and unexpected " lol . This Clown has no shame , and It's impressive how long he's been riding the NR2F6 train . Compared to other biotech's IP's this "science" is outdated at best . Dont take my word for it -Research it , even the Nasdaq delinquent company's have more credibility and actual phase trials underway . Koo's really is a conman , spinning the crap anyway he can . Flip it , make some money if possible , don't fall for the BS tho . Been there , done that .
This is HUGE News...
The Company has now received the complete set of confirmatory data performed by a second contract research organization (CRO) which is independent of the CRO which performed the initial experiments. These data confirm that T cells which express the chimeric antigen receptor (CAR) construct targeting CD19 and expressing siRNA for NR2F6 had high expression levels of NR2F6 mRNA. NR2F6 is considered an immune checkpoint and thus increasing its activity is likely to lead to immune suppression.
$RGBP
WOW! HUGE NEWS! THIS SHOULD POP TO $2 JUST ON THIS CONFIRMATORY NEWS ALONE BECAUSE IT MEANS REGEN HAS CURED CANCER! AND THIS NEWS WILL MEAN KOOSIE WILL GET THAT FUNDING HE WAS PROMISED BUT DIDN'T GET AFTER THE REVERSE SPLIT, RIGHT?
The Company has now received the complete set of confirmatory data performed by a second contract research organization (CRO) which is independent of the CRO which performed the initial experiments. These data confirm that T cells which express the chimeric antigen receptor (CAR) construct targeting CD19 and expressing siRNA for NR2F6 had high expression levels of NR2F6 mRNA. NR2F6 is considered an immune checkpoint and thus increasing its activity is likely to lead to immune suppression.
$RGBP
Couscous is a crook and an inveterate liar who has in the past killed several companies. You have to be stupid to still believe this big pig who puts out bogus PRs for naive and gullible traders.....LOOOOL !!!
A compensation to promote this stock is going to be huge for every long here, maybe sooner than expected
How much are you being compensated to promote this fraudulent garbage?
News: Regen BioPharma, Inc. Receives Second Phase Confirmatory Data on its Duracar CAR-T Cell Therapy Program $RGBP @TheRegenBio #mRNA #autoimmunity #FDA #pfizer $PFE #NEWS
NEWS PROVIDED BY
Regen BioPharma Inc.
25 Oct, 2023, 09:30 ET
Autoimmunity to be Targeted
SAN DIEGO, Oct. 25, 2023 /PRNewswire/ -- Regen BioPharma, Inc. (OTC PINK: RGBP) (OTC PINK: RGBPP) has previously discussed initiation of a series of experiments to validate its DuraCAR CAR T-cell therapeutic (https://www.prnewswire.com/news-releases/regen-biopharma-inc--begins-experiments-validating-its-proprietary-car-t-cell-therapy-301623585.html) while also identifying new, unexpected and potentially extremely useful findings in developing cell therapy treatments for autoimmune disorders https://www.prnewswire.com/news-releases/studies-on-regen-biopharma-incs-duracar-indicate-potential-suppression-of-autoimmunity-company-retains-contract-research-organization-to-conduct-additional-confirmatory-studies-301931365.html.
The Company has now received the complete set of confirmatory data performed by a second contract research organization (CRO) which is independent of the CRO which performed the initial experiments. These data confirm that T cells which express the chimeric antigen receptor (CAR) construct targeting CD19 and expressing siRNA for NR2F6 had high expression levels of NR2F6 mRNA. NR2F6 is considered an immune checkpoint and thus increasing its activity is likely to lead to immune suppression.
"Being able to substantially elevate NR2F6 levels is truly an unexpected, but welcome finding. We now have a sound scientific basis to pursue designing T cells which can tamp down on the uncontrolled immune activation seen in multiple autoimmune disorders," says Dr. Harry Lander, Chief Scientific Consultant to the Company. "We recently filed a patent application around such T cells and we feel we have a head start on this in the scientific community, particularly around using nuclear receptors such as NR2F6."
"Having a second confirmatory study gives us confidence we are making the right decision to pursue these novel cell therapies focused on autoimmunity," says Dr. David Koos, Chairman and CEO of the company. "I expect that after consulting with our Board of Advisors and internally, the Company will soon have a clear picture of the specific indications and approaches it will pursue."
About Regen BioPharma Inc.:
Regen BioPharma, Inc. is a publicly traded biotechnology company (PINK: RGBP) and (PINK: RGBPP). The Company is focused on the immunology and immunotherapy space. The Company is focused on rapidly advancing novel technologies through pre-clinical and Phase I/ II clinical trials. Currently, the Company is focused on mRNA and small molecule therapies for treating cancer and autoimmune disorders. Additional information on Regen BioPharma is available at http://www.regenbiopharmainc.com.
Disclaimer: This news announcement may contain forward-looking statements. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements. The risks and uncertainties to which forward looking statements are subject include, but are not limited to, the effect of government regulation, competition and other material risks.
CONTACT INFORMATION:
Regen BioPharma Inc.
David R. Koos, Ph.D.
Chairman & Chief Executive Officer
+1-619-722-5505 Phone
+1-619-330-2328 Fax
Email: david.koos@regenbiopharmainc.com or david.koos@regenbiopharma.com
Twitter (now X): https://twitter.com/TheRegenBio
SOURCE Regen BioPharma Inc.
https://www.prnewswire.com/news-releases/regen-biopharma-inc-receives-second-phase-confirmatory-data-on-its-duracar-car-t-cell-therapy-program-301967324.html
It's trading at its 10-day average volume as lunchtime approaches on today's News... UP almost 14%. Looking good.
$RGBP
Been awhile since I’ve seen this one, did this have a reverse split to get over $1? Last I saw this it was a trip zero stock.
OMG MOAR GREAT NEWS THAT WILL CATAPULT THIS TURD TO DA MOON!
Let me once again explain that pre clinical lab testing generating a pre determined outcome is about as meaningful as Koos' bowel movements after a night of him eating taco bell. These tests tell us nothing. Koos will never get any of this into true in vivo clinical trials. He's a failure just as those promoters trying to pump the share price up with their vapid posts.
https://finance.yahoo.com/news/regen-biopharma-inc-receives-second-133000496.html
Another friendly reminder that all of the great things that the promoters promised were going to happen never did. There has only been one person that has been right about this turd and konman of a CEO for years now...and that has been me. And remember how Koos told his investors that a reverse split needed to happen because his investors told him that without it, he wouldn't get funding. Well, those investors never did invest in the company after the reverse split. Some "business leader" Koos is, amirite?
Keep posting the pumperdumper news! It is Working! Look how the pps is sky rocketing!
RGBP plans to rapidly advance novel technologies through pre-clinical and Phase I/ II clinical trials. Currently, RGBP is advancing therapies for treating cancer and autoimmune disorders by modulating the immune checkpoint NR2F6. RGBP is also developing products treating blood disorders using small molecules and gene silencing (DiffronC), treating cancer with cellular immunotherapy (dCellVax, tCellVax, Dura-CAR, KimerApt), modulating key molecular processes in cancer stem cell through its patented molecular targeting approaches (BORIS), and repairing damaged bone marrow in patients with aplastic anemia and chemotherapy/radiotherapy treated cancer patients (HemaXellerate).
$RGBP Great Article out: Development Data for mRNA & Small Molecule Immunotherapies for Treating Cancer: Regen BioPharma,: Stock Symbol: RGBP
https://apnews.com/press-release/ein-presswire-newsmatics/gene-therapy-cancer-preventive-care-aa5091e545b2018757bbf6e85cc3468b
$RGBP Agreed looking for that move on the chart.
This is a trash stock run by a konman. Where is that white paper that David paid his gyno brother $300K for? Where is that capital raise David said would happen if he did the reverse stock split?
What a joke. The fat bastard now has a few paid posters on here trying to get the pps back to $2.
The con is back on!
$RGBP Regen BioPharma, Inc. Expects Second Phase of Confirmatory Study Shortly https://finance.yahoo.com/news/regen-biopharma-inc-expects-second-120000951.html?soc_src=social-sh&soc_trk=tw&tsrc=twtr via @YahooFinance
"We know our shareholders are anxious to hear about our results surrounding modifying NR2F6 levels in CAR T-cells and we will get this data out as soon as we can," says Dr. David Koos, Chairman and CEO of the company.
"A second unrelated CRO is currently performing qRT-PCR tests to determine if NR2F6 mRNA is elevated or inhibited by our CAR in T-Cells," says Dr. Harry Lander, Chief Scientific Consultant to the Company." If NR2F6 mRNA is suppressed (stimulating certain immune functions) then this product shows potential for treatment of cancer and if NR2F6 mRNA is elevated (suppressing certain immune functions) then the product shows potential for treatment of autoimmune disorders."
Too funny and quoting pumper stumper...must be a joke
Oh how I love the smell of desperation in the morning when the goobers post the same spam multiple times.
They’re “scared” all right- scared of the short squeeze & scared their masters won’t pay them for their repetitive spam.
LMAO
O11
Regen BioPharma Inc (RGBP)
Post#
112058
of 118128
pumper_stumper
Re: None
Friday, 08/12/2022 2:28:53 PM
"David Koos Scares Me - I just dumped all my shares. I should have done more research into the CEO and the company. It may get pumped again and some may make a little, but this whole thing seems to scammy for my money.
I bought RGBP because they made a deal with OPNH. I really thought they had something... I really wanted this stock to work out. Taking my loss...
You can google "david koos scam" and find all kinds of information.
In 2005, he was part of GISBeX offshore stock exchange scam. He got out early neough to no bet prosecuted. He did not serve jail time, but others did. https://www.sandiegoreader.com/news/2005/mar/17/penny-swindlers/
It is alarming how man issues this Koos guy has run into. I have no idea how I missed it. (https://casetext.com/case/starcity-capital-llc-v-bio-matrix-scientific-grp)
The item that caught my eye is that he is a CEO of two companies and they both made deals with OPNH. I am not sure how it is all connected, but again seems sketchy.
I hope you all the best, but proceed with caution and do a few google searches."
- From a former shareholder!
https://www.sandiegoreader.com/news/2005/mar/17/penny-swindlers/
https://casetext.com/case/starcity-capital-llc-v-bio-matrix-scientific-grp/
https://www.otcmarkets.com/stock/ONPH/news/Oncology-Pharma-Signs-Worldwide-Licensing-Agreement-with-Sybleu-Inc-for-Commercialization-of-Chemotherapeutic-Agent-in-C?id=291550
https://www.streetinsider.com/dr/news.php?id=20958272
https://www.nanalyze.com/2014/03/big-red-flags-from-bio-matrix-and-regen-biopharma/
Regen BioPharma Inc (RGBP)
Post#
112058
of 118128
pumper_stumper
Re: None
Friday, 08/12/2022 2:28:53 PM
"David Koos Scares Me - I just dumped all my shares. I should have done more research into the CEO and the company. It may get pumped again and some may make a little, but this whole thing seems to scammy for my money.
I bought RGBP because they made a deal with OPNH. I really thought they had something... I really wanted this stock to work out. Taking my loss...
You can google "david koos scam" and find all kinds of information.
In 2005, he was part of GISBeX offshore stock exchange scam. He got out early neough to no bet prosecuted. He did not serve jail time, but others did. https://www.sandiegoreader.com/news/2005/mar/17/penny-swindlers/
It is alarming how man issues this Koos guy has run into. I have no idea how I missed it. (https://casetext.com/case/starcity-capital-llc-v-bio-matrix-scientific-grp)
The item that caught my eye is that he is a CEO of two companies and they both made deals with OPNH. I am not sure how it is all connected, but again seems sketchy.
I hope you all the best, but proceed with caution and do a few google searches."
- From a former shareholder!
https://www.sandiegoreader.com/news/2005/mar/17/penny-swindlers/
https://casetext.com/case/starcity-capital-llc-v-bio-matrix-scientific-grp/
https://www.otcmarkets.com/stock/ONPH/news/Oncology-Pharma-Signs-Worldwide-Licensing-Agreement-with-Sybleu-Inc-for-Commercialization-of-Chemotherapeutic-Agent-in-C?id=291550
https://www.streetinsider.com/dr/news.php?id=20958272
https://www.nanalyze.com/2014/03/big-red-flags-from-bio-matrix-and-regen-biopharma/
Regen BioPharma Inc (RGBP)
Post# 112058 of 118128
pumper_stumper
Re: None
Friday, 08/12/2022 2:28:53 PM
"David Koos Scares Me - I just dumped all my shares. I should have done more research into the CEO and the company. It may get pumped again and some may make a little, but this whole thing seems to scammy for my money.
I bought RGBP because they made a deal with OPNH. I really thought they had something... I really wanted this stock to work out. Taking my loss...
You can google "david koos scam" and find all kinds of information.
In 2005, he was part of GISBeX offshore stock exchange scam. He got out early neough to no bet prosecuted. He did not serve jail time, but others did. https://www.sandiegoreader.com/news/2005/mar/17/penny-swindlers/
It is alarming how man issues this Koos guy has run into. I have no idea how I missed it. (https://casetext.com/case/starcity-capital-llc-v-bio-matrix-scientific-grp)
The item that caught my eye is that he is a CEO of two companies and they both made deals with OPNH. I am not sure how it is all connected, but again seems sketchy.
I hope you all the best, but proceed with caution and do a few google searches."
- From a former shareholder!
https://www.sandiegoreader.com/news/2005/mar/17/penny-swindlers/
https://casetext.com/case/starcity-capital-llc-v-bio-matrix-scientific-grp/
https://www.otcmarkets.com/stock/ONPH/news/Oncology-Pharma-Signs-Worldwide-Licensing-Agreement-with-Sybleu-Inc-for-Commercialization-of-Chemotherapeutic-Agent-in-C?id=291550
https://www.streetinsider.com/dr/news.php?id=20958272
https://www.nanalyze.com/2014/03/big-red-flags-from-bio-matrix-and-regen-biopharma/
Regen BioPharma Inc (RGBP)
Post# 112058 of 118128
pumper_stumper
Re: None
Friday, 08/12/2022 2:28:53 PM
"David Koos Scares Me - I just dumped all my shares. I should have done more research into the CEO and the company. It may get pumped again and some may make a little, but this whole thing seems to scammy for my money.
I bought RGBP because they made a deal with OPNH. I really thought they had something... I really wanted this stock to work out. Taking my loss...
You can google "david koos scam" and find all kinds of information.
In 2005, he was part of GISBeX offshore stock exchange scam. He got out early neough to no bet prosecuted. He did not serve jail time, but others did.
https://www.sandiegoreader.com/news/2005/mar/17/penny-swindlers/
It is alarming how man issues this Koos guy has run into. I have no idea how I missed it. (https://casetext.com/case/starcity-capital-llc-v-bio-matrix-scientific-grp)
The item that caught my eye is that he is a CEO of two companies and they both made deals with OPNH. I am not sure how it is all connected, but again seems sketchy.
I hope you all the best, but proceed with caution and do a few google searches."
- From a former shareholder!
https://www.sandiegoreader.com/news/2005/mar/17/penny-swindlers/
https://casetext.com/case/starcity-capital-llc-v-bio-matrix-scientific-grp/
https://www.otcmarkets.com/stock/ONPH/news/Oncology-Pharma-Signs-Worldwide-Licensing-Agreement-with-Sybleu-Inc-for-Commercialization-of-Chemotherapeutic-Agent-in-C?id=291550
https://www.streetinsider.com/dr/news.php?id=20958272
https://www.nanalyze.com/2014/03/big-red-flags-from-bio-matrix-and-regen-biopharma/
pre clinical lab tests to confirm pre clinical lab tests.
This is routine in pre clinical testing and hardly something to put out a pr UNLESS you are a STINKY PINKY trying to pump up your pathetic pps.
Koos is the classical OTC scam artist CEO.
His pathetic track record with his public companies should be a warning to others but there are always those that love to gamble on scam artist run OTC companies in the hope of making a quick buck.
Regen BioPharma, Inc. Expects Second Phase of Confirmatory Study Shortly
SAN DIEGO, Oct. 18, 2023 PRNewswire
Regen BioPharma, Inc. (OTC-PINK: RGBP) (OTC-PINK: RGBPP) is currently developing a genetic approach to regulating NR2F6 levels in human T cells. The Company has recently received unexpected and potentially extremely useful data from one of its contract research organizations (CRO) retained to perform experimental studies on the Company's DuraCAR CAR T-cell therapeutic. These studies demonstrated that T cells which express the chimeric antigen receptor (CAR) construct expressing siRNA for NR2F6 can be successfully created.
"A second unrelated CRO is currently performing qRT-PCR tests to determine if NR2F6 mRNA is elevated or inhibited by our CAR in T-Cells," says Dr. Harry Lander, Chief Scientific Consultant to the Company." If NR2F6 mRNA is suppressed (stimulating certain immune functions) then this product shows potential for treatment of cancer and if NR2F6 mRNA is elevated (suppressing certain immune functions) then the product shows potential for treatment of autoimmune disorders."
Once the Company receives the data, it will analyze the results and report the findings in a press release in order to keep the company's shareholders informed of its progress.
"We know our shareholders are anxious to hear about our results surrounding modifying NR2F6 levels in CAR T-cells and we will get this data out as soon as we can," says Dr. David Koos, Chairman and CEO of the company.
Followers
|
1050
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
118423
|
Created
|
09/03/14
|
Type
|
Free
|
Moderators Huggy Bear SmellMyFinger |
0.000x Ticker Symbol: RGBP
Barchart
All other Regen BioPharma News
https://www.regenbiopharmainc.com/company-news.html
Date | Outsanding Shares | Reason for Issue |
---|---|---|
12/31/21 | 4,564,002,832 | |
3/28/22 | 4,580,002,832 | Debt and Interest |
4/7/22 | 4,736,002,832 | Debt and Interest |
5/16/22 | 4,820,002,832 | Debt |
7/1/22 | 4,920,002,832 | Debt |
7/17/22 | 4,970,002,832 | Debt and Interest |
8/1/22 | 5,024,517,324 | Debt |
8/4/22 | 5,031,517,324 | EXPENSES |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |